Michael Rousseau will become president and CEO of medical-device Daniel maker St. Jude Medical when Starks retires at the end of the year. Rousseau, 59, will take the helm on Jan. 1, replacing Starks, who will retain the title of executive board chairman at the St. Paul, Minn.-based company.
Starks pointed to St. Jude’s atrial fibrillation portfolio, Cardio MEMS heart failure monitor and neuromodulation products for chronic pain as drivers of growth during his 11-year tenure.
Rousseau joined St. Jude in 1999 as senior VP of cardiac rhythm management global marketing, which later was combined with the division’s sales team. In January 2008, he was promoted to group president and oversaw the company’s four product divisions before being named COO in 2014.